Gypenosides activate AMPK — the master metabolic sensor that responds to low cellular energy. AMPK activation: (1) increases glucose uptake in muscle cells (independent of insulin); (2) inhibits hepatic gluconeogenesis (reduces liver glucose output); (3) stimulates fatty acid oxidation; (4) inhibits lipogenesis. This is pharmacologically similar to metformin's mechanism, which is why the blood sugar reduction is significant. Additional mechanisms include NO-mediated vasodilation, SOD upregulation (antioxidant), and NF-κB suppression (anti-inflammatory).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.